DOI: 10.1128/AAC.02031-18
Article Information
PubMed
Published By
History
- Received October 4, 2018
- Returned for modification December 15, 2018
- Accepted June 2, 2019
- Published online August 23, 2019.
Copyright & Usage
Copyright © 2019 Nakamura et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (July 01, 2019).
- Accepted Manuscript version (July 29, 2019).
- You are viewing the most recent version of this article.
Author Information
- Rio Nakamuraa,
- Tsukasa Ito-Horiyamaa,
- Miki Takemuraa,
- Shinsuke Tobaa,
- Shuhei Matsumotoa,
- Tatsuya Ikeharaa,
- Masakatsu Tsujia,
- Takafumi Satoa and
- Yoshinori Yamanoa
- Address correspondence to Rio Nakamura, rio.nakamura{at}shionogi.co.jp.
Citation Nakamura R, Ito-Horiyama T, Takemura M, Toba S, Matsumoto S, Ikehara T, Tsuji M, Sato T, Yamano Y. 2019. In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models. Antimicrob Agents Chemother 63:e02031-18. https://doi.org/10.1128/AAC.02031-18.
